A large number of different approaches for the aqueous phase transfer of quantum dots have been proposed. Surface ligand exchange with small hydrophilic thiols, such as L-cysteine, yields the lowest particle hydrodynamic diameter. However, cysteine is prone to dimer formation, which limits colloidal stability. We demonstrate that precise pH control during aqueous phase transfer dramatically increases the colloidal stability of InP/ZnS quantum dots. Various bifunctional thiols have been applied. The formation of disulfides, strongly diminishing the fluorescence QY has been prevented through addition of appropriate reducing agents. Bright InP/ZnS quantum dots with a hydrodynamic diameter <10 nm and long-term stability have been obtained. Finally we present in vitro studies of the quantum dots functionalized with the cell-penetrating peptide maurocalcine.
INTRODUCTION
In recent years a large number of methods for the aqueous phase transfer of CdSe based quantum dots, synthesized in organic solvent, have been developed [1] . Among those, surface ligand exchange with small hydrophilic thiols has been shown to yield the lowest hydrodynamic diameter, on the order of 5-10 nm [2] . Compact quantum dots are required for specific imaging applications (e.g. sentinel lymph node detection, study of synaptic signaling) and for maximizing renal excretion following in vivo intravenous injectino [3] [4] [5] . Thiol-containing amino acids such as L-cysteine are of particular interest as capping ligands for hydrosoluble quantum dots as they exhibit low non-specific binding to serum proteins due to their zwitterionic character. However, cysteine is prone to dimer formation, yielding cystine, which limits the colloidal stability of the quantum dots.
Here we demonstrate that the precise control of the pH value during aqueous phase transfer dramatically increases the colloidal stability of InP/ZnS quantum dots. While precipitation of the quantum dots in PBS buffer typically occurs within one day, DLS measurements show that no aggregation takes place even after several weeks in case of the correct choice of the pH during the transfer reaction. In addition to cysteine, various other bifunctional thiols have been tested. Depending on the phase transfer ligand, the pH has to be chosen in a range of 8-10 according to the pK a value of the thiol function. The thiolate ion exhibits a much stronger binding to the quantum dot surface than the thiol. At the same time, the formation of disulfides has been prevented during phase transfer through addition of appropriate reducing agents. Disulfides not only reduce the colloidal stability but also significantly diminish the fluorescence quantum yield (QY) of InP/ZnS quantum dots. This effect is most pronounced (around 10% of QY retained) in the case of cysteine or dihydrolipoic acid used as phase transfer agents. To the contrary, in our procedure up to 90% of the initial QY is maintained. The resulting quantum dots emit in the range of 650-700 nm and exhibit a QY of 10% in PBS buffer at pH 7.4. Their hydrodynamic diameter lies below 10 nm and does not vary over several weeks. Finally we will present first in vitro studies of the hydrosoluble quantum dots after surface functionalization with the cell penetration peptide maurocalcine.
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RESULTS AND DISCUSSION

Aqueous phase transfer
Aqueous phase transfer of InP/ZnS quantum dots (QDs) synthesized in 1-octadecene and capped with myristic acid/stearic acid is achieved by the vigorous stirring of a biphasic mixture of the initial particles in chloroform and of the transfer ligand in deionized water (Fig. 1a) . The key feature for obtaining high colloidal stability is the precise control of the pH value of the aqueous phase containing the transfer ligand. On the one hand, the pH has to be high enough to deprotonate the thiol function of the transfer ligand. The thiolate function has been shown to have a much higher binding energy on QD surfaces than the thiol group [6] . On the other hand, elevated pH values promote the formation of disulfide bonds, which lead to weaker binding to the QD surface and to fluorescence quenching (see below). A number of bifunctional thiols has been investigated, namely DHLA (dihydrolipoic acid), Cys (L-cysteine), MPA (mercaptopropionic acid), Pen (D-penicillamine). Fig. 1c , showing the quantum dots in 1X PBS buffer at pH 7.4 under UV light, demonstrates that the fluorescence intensity of the QDs is strongly affected by the nature of the transfer ligand. However, both the UV-vis absorption and PL spectra remain essentially unchanged during the phase transfer as far as the peak position and line width are concerned (Fig. 1d) . In order to identify the appropriate pH value for the phase transfer, titration curves of the different ligands were established using tetramethylammonium hydroxide (TMAH) as the base. Table 1 lists the obtained pK a values of the thiol function of the different ligands studied (for DHLA: first thiol group). The pH value of the aqueous phase used in the transfer reaction was chosen to be slightly above pK a (thiol). Table 1 
Nuclear magnetic resonance and dynamic light scattering measurements
After 24 hrs the samples exchanged with Cys exhibited a white precipitate, which cannot result from the aggregation of the (dark red) quantum dots. By means of 1 H-NMR we identified this precipitate as being composed of cystine, the dimerisation product of cysteine (Fig. 2) . Cystine is insoluble in water at neutral pH. Therefore the precipitate was dissolved in a D 2 O/ NaOH mixture at pH 11. In L-cysteine (not shown), the methine proton and the methylene protons in α-position of the thiol function have chemical shifts of 3.9 and 2.95 ppm, respectively. In the case of cystine precipitating from the quantum dots solution, the signal of the methine protons is shifted upfield to 3.46 ppm. The methylene protons split into two multipletts at 3.00 and 2.78 ppm, respectively, owing to the molecular chirality of the component (Fig. 2a) . For comparison, the spectrum of pure L-cysteine (i.e. without quantum dots) kept at pH 9 in D 2 O during 24 hrs is also presented (Fig. 2b) . The principal peaks of the obtained spectrum match those of the quantum dot solution. Both spectra are also in accordance with the data reported by Katritzky et al. and can therefore be unambiguously assigned to cystine [7] . It is well known that L-cysteine shows a strong tendency to generate insoluble cystine in the human body, which is one of the reasons for the formation of kidney stones. To the contrast, Dpenicillamine is much less prone to dimerization and can even be used as a treatment of cystinuria thanks to the solubility of cysteine-penicillamine disulfide [8] . For the various ligands studied, the degree of PL quenching can be correlated to their different tendency for disulfide formation. Disulfides such as cystine have been shown to efficiently quench the PL of CdTe quantum dots due to hole transfer [9] . We therefore prevented disulfide formation by the addition of an appropriate reducing agent during the phase transfer, such as tris(2-carboyethyl)phosphine hydrochloride (TCEP). In this case, up to 90% of the initial PL quantum yield was retained, which is a significant improvement with respect to reported methods relying on ligand exchange for the water solubilization of quantum dots. 1 H-NMR spectra of (a) cystine recovered from NCs solution after 24 hrs and (b) cystine formed when a solution of cysteine at pH~9 is kept for 24 hrs at room temperature. The spectra were recorded in a D 2 O/NaOH mixture at pH 11. The hydrodynamic diameter of the transferred InP/ZnS quantum dots was assessed by dynamic light scattering measurements. Importantly, the hydrodynamic diameter of Cys-or Pen-capped quantum dots is below 10 nm and no aggregation was detected for long periods of time up to several months (Fig. 3) . We believe that strong ligand binding to the nanocrystals surface via the thiolate group is at the origin of the observed, significantly increased long-term stability as compared to exchange reactions carried out without pH control [10] . 
AQUEOUS PHASE TRANSFER OF INP/ZNS QUANTUM DOTS
Chiral properties and in vitro studies of Pen-capped quantum dots
In the case of chiral D-penicillamine ligands, we carried out circular dichroism (CD) measurements. Fig. 4 illustrates that the Pen-functionalized quantum dots retain the chiral character of the capping molecules and exhibit a modified CD spectrum as compared to pure D-penicillamine. Gun'ko and coworkers synthesized chiral quantum dots in the presence of D-or L-penicillamine [11, 12] . CD active luminescent nanocrystals are believed to have a high potential for the development of new chiral nanosensors. Our results indicate that chiral quantum dots can be obtained by post-synthetic ligand exchange, which gives an additional degree of freedom with respect to the use of optically active ligands during the synthesis. Finally we demonstrate the possibility of using Pen-capped InP/ZnS quantum dots as a platform for further surface functionalization in view of biological applications. In this context, we used the cell penetrating peptide maurocalcine (MCa), which is able to bind to the quantum dot surface via the thiol function of one cysteine group [13] . MCa conjugation to the nanocrystals' surface was easily achieved by incubating the quantum dots in a solution containing an approximately 10-fold molar excess of MCa. After purification using centrifuge filters with a cut-off of 50 kDa, the MCa-functionalized quantum dots were used for incubation with Chinese hamster ovary (CHO) cells in culture (2 hrs). Fig. 5 demonstrates successful cell penetration of the MCa-modified quantum dots, whereas no penetration was observed with Pen being the only surface ligand. These results confirm that MCa is indeed bound to the nanocrystals' surface and that it retains its cell-penetration properties upon conjugation. Further experiments using tumor-targeting peptides in addition to MCa are currently underway in our laboratory, with the goal to demonstrate the versatility of the chosen approach and to provide multifunctional nanoprobes for biological applications. 
EXPERIMENTAL SECTION
All reagents were purchased from Sigma-Aldrich and used as received. The synthesis of InP/ZnS quantum dots follows the procedure reported in Ref. 14.
Aqueous phase transfer: The transfer ligand is dissolved in 1 mL of degassed MilliQ water to yield a 0.2 M solution and the pH is adjusted to the value specified in Table 1 by drop-wise addition of 0. 5M tetramethylammonium hydroxide. This solution is mixed with 1 mL of a ~5 μM dispersion of the InP/ZnS QDs in chloroform. The biphasic mixture is stirred vigorously for 2 h. The mixture is then centrifuged at 6,000 rpm for 1 min to obtain a clear phase separation. The QDs in the (upper) aqueous phase are separated from the (lower) organic phase. 200 μL of the QDs in water are centrifuged in a Millipore centrifugal filter (VWR, MWCO 30k) at 10,000 rpm for 2 min. The QDs are redispersed in 200 μl of 1X PBS buffer (pH~7.4) or MilliQ water and stored in a fridge (~4 o C).
Conjugation of MCa on the surface of InP/ZnS nanocrystals: The peptide-QDs conjugation is achieved by overnight incubation of the peptide with NCs in a slightly basic pH, in a reaction similar to the one reported for colloidal gold nanoparticles [15] . Typically, 300 μl (0.5μM) of QDs are mixed with 2 mg of MCa in 400 μL of borate buffer.
Measurement of the hydrodynamic diameter: The hydrodynamic diameter of the water-soluble NCs dispersed is measured by dynamic light scattering (DLS), using a Malvern Zeta Sizer (NanoZS). Prior to the measurements, the samples are thoroughly purified with centrifugal filters from (VWR MWCO 30k) and dispersed in 1X PBS buffer. Multiple runs (>3) were performed to avoid erroneous results. The data is collected in automatic mode and is expressed in number %.
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